Next Quarterly Earnings
No earnings planned
Currently, no future quarterly earnings are announced for this company.Acquired
Arcellx is no longer listed independently and no longer reports its own quarterly results. 
Arcellx
Arcellx is a US-based biotechnology company developing innovative cell therapies for cancer patients. The company focuses on the clinical investigation of novel CAR-T cell therapies to improve treatment outcomes for challenging diseases. Arcellx is advancing immunotherapy to revolutionize patient care.
Frequently asked questions
When did Arcellx last report quarterly earnings?
Arcellx last reported quarterly earnings on 11/5/2025 (Q3 2025).
How often has Arcellx beaten expectations?
Arcellx has beaten analyst EPS estimates in 3 of its last 4 evaluated quarters (beat rate: 75%).
How do I add the Arcellx earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
3/4
Quarters above estimates
75%
Beat rate
-0.1%
Avg. EPS surprise
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Arcellx
Country
🇺🇸
More Financial Information